D-0437-2024 Class II Terminated
FDA drug recall D-0437-2024 was initiated by Lupin Pharmaceuticals Inc. on March 21, 2024 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated April 4, 2025). Affected quantity: 26,352 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- April 17, 2024
- Initiation Date
- March 21, 2024
- Termination Date
- April 4, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 26,352 bottles
Product Description
Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06
Reason for Recall
Subpotent Drug
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: A201064, Exp. Date March 2024